Skip to content

Clinical trials

Phase 3 Fallopian Tube Neoplasms trials in Norway

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Fallopian Tube Neoplasms Phase: Phase 3 Country / region: Norway Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20061
20091
20111
20171
20211
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Active, not recruiting2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AGO Study Group2
Eli Lilly and Company1
European Organisation for Research and Treatment of Cancer - EORTC1
Genmab1
Hoffmann-La Roche1
Medical Research Council1
Merck Sharp & Dohme LLC1
Nordic Society of Gynaecological Oncology - Clinical Trials Unit1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Fallopian Tube Neoplasms10
Ovarian Neoplasms10
Carcinoma, Ovarian Epithelial5
Peritoneal Neoplasms3
Brenner Tumor1
Genital Diseases, Female1
Neoplasm Metastasis1
Ovarian Diseases1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.